US Patent Issued to Seattle Project on June 16 for "Alphavirus neoantigen vectors and interferon inhibitors" (California Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,883, issued on June 16, was assigned to Seattle Project Corp. (Dover, Del.).

"Alphavirus neoantigen vectors and interferon inhibitors" was invented by Karin Jooss (Emeryville, Calif.), Amy Rachel Rappaport (San Francisco) and Leonid Gitlin (Foster City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are vectors that include alphavirus-based expression platforms. Also disclosed are methods associated with the alphavirus-based expression platforms and co-administration of an inhibitor of Type I interferon signaling."

The patent was filed on Nov. 7, 2019, under Application No. 17/291,984.

*For further information, including im...